FDA Issues New Guidance for Collecting Postmarketing Data on Underrepresented Patient Populations | BakerHostetler

In a notable step toward more equitable healthcare, the U.S. Food and Drug Administration (FDA) introduced new draft guidance on August 10, Postmarketing Approaches to Obtain Data on...

Related Keywords

,Drug Administration ,Postmarketing Approaches ,Obtain Data ,Populations Underrepresented ,Clinical Trials ,Biological Products ,Postmarketing Requirements ,Postmarketing Commitments ,